US 9353108
Tetrahydronaphthyridine somatostatin receptor 5 antagonists
granted A61PA61P3/00A61P3/10
Quick answer
US patent 9353108 (Tetrahydronaphthyridine somatostatin receptor 5 antagonists) held by Takeda Pharmaceutical Company Limited expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P3/00, A61P3/10, A61P43/00, A61P9/00